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ABSTRACT: The facile Copper-catalyzed synthesis of polysubstituted pyrroles from aldehydes, 
amines and β-nitroalkenesis reported. Remarkably, the use of α-methyl substituted aldehydes 
provide efficient access to a series of tetra- and pentasubstituted pyrroles via an overwhelming 1,2-
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phenyl/alkyl migration. The present methodology is also accessible to non α-substituted aldehydes 
yielding the corresponding trisubstituted pyrroles. On the contrary, the use of ketones, in place of 
aldehydes, does not promote the organic transformation signifying the necessity of α-substituted 
aldehydes. The reaction proceeds under mild catalytic conditions with low catalyst loading (0.3 – 
1 mol %), a broad scope, very good functional-group tolerance, high yields and can be easily scaled 
up to more than 3 mmol of product, thus highlighting a useful synthetic application of the present 
catalytic protocol. Based on formal kinetic studies, a possible radical pathway is proposed that 
involves the formation of an allylic nitrogen radical intermediate, which in turn reacts with the 
nitroalkene to yield the desired pyrrole framework via a radical 1,2-phenyl or alkyl migration.  
 
INTRODUCTION 
Pyrroles represent one of the most important five-membered N-containing heterocyclic 
scaffolds and key structural cores in natural products with bioactive and therapeutic properties.1 
Several synthetic strategies including the well-known Hantzsch, Knorr, and Paal-Knorr synthesis 
have been developed to harvest the pyrrole framework.2 At present, emphasis is given on the 
development of 3d transition metal based catalysts as well multicomponent reactions (MCRs) for 
high atom economy, bond-forming efficiency as well minimization of waste, time, and cost.2,3 An 
interesting approach towards the synthesis of pyrroles is based on MCRs incorporating β-
nitrostyrenes; the latter are versatile electrophiles and have extensively been used in heterocycle 
synthesis.4,5 To date, four methodologies report the use of the nitrostyrene scaffold to produce 
pyrroles; the Crob-Camenisch includes β-enamino-carbonyl compounds as key intermediates 
(Scheme 1, i),6,7 the Barton-Zard incorporates the formation of α-isocyanide carbonyl enolate 
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(Scheme 1, ii),8 the “Lego method” uses β-bromo nitrostyrenes under enamine catalysis (Scheme 
1, iii)9 and the [3+2] cycloaddition protocol of azomethineylide intermediates with nitrostyrenes 
(Scheme 1, iv).10 Consequently, the efficient and versatile synthesis of poly-substituted pyrroles, 
by easily accessible precursors, wide diversity and precise introduction of substituents into a 
certain position on the pyrrole ring, remains a great challenge. 
Our groups have developed successful protocols for organic transformations promoted by a 
family of one dimensional (1D) Copper based coordination polymers (CPs).11 These CPs are made 
from commercial available starting materials, in two steps and excellent yields and promote the 
chemical transformations with catalyst loadings of one order of magnitude lower when compared 
to metal salts, in better yields and, most importantly, absence of by-products.11 Herein, we employ 
this catalytic library in the MCR of α-substituted aldehydes, amines and β-nitroalkenes (Scheme 
1, v) that yields polysubstituted pyrroles in a fast and regioselective manner via an 1,2-phenyl/alkyl 
migration. Notwithstanding, few similar MCR protocols have been reported, however our current 
methodology has significant variations and benefits. For example, the MCR studies that involved 
aldehydes or cycloketones, promoted by Sm(Oi-Pr)3
12a or in absence of catalyst,12b required 
multistep and stepwise protocol with imine formation and isolation,12a as well as showed limited 
applicability.12b Moreover, the use of silica gel13a or alumina13b under microwave conditions or the 
molten ammonium salt13c promote the pyrrole formation, however only a limited variation of 2-
methyl or 2-ethyl substituted pyrroles can be produced starting with the corresponding β-methyl 
or ethyl substituted nitroalkenes. 
 




RESULTS AND DISCUSSIONS 
The present catalytic protocol involves the reaction of 2-phenyl propionaldehyde (1), butyl 
amine (BuNH2), and (E)-1-methyl-4-(2-nitrovinyl)benzene (2), catalyzed by various copper 
[Cu(II) and Cu(I)] salts (see Table 1) and the recently reported CPs formulated 
[M(II)(L)2(Z)2]·2(ClO4)·2MeCN (M=Cu, Z=MeCN, Cu-1), [Cu(II)(L)2(NO3)2] (Cu-2), 
[Cu(II)(L)2(MeCN)2]·2BF4 (Cu-3), [Cu(II)(L)2(OTf)2] (Cu-4), L is 1-{2-
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[(1Hbenzo[d][1,2,3]triazol-1-yl)methyl]benzyl}1Hbenzo-[d][1,2,3]triazole.11 The reaction is 
carried out into a sealed tube with equimolar amounts of 1, BuNH2 and 2 in 1 mL of MeOH at 80 
oC for 1h. The alcoholic media promotes this transformation and MeOH gives the optimum results 
(screening tests in Tables S1). Under these conditions, Cu salts consume 2 in full, but show low 
or medium activity towards the synthesis of pyrrole 3 (Table 1, entries 1-10), as observed by 1H 
NMR of the crude mixtures (Table 1). In all cases, two by-products were observed; acetophenone 
(1a) that is formed via an oxidative transformation from 1 (Figure S1),14 and p-tolualdehyde (2a) 
that is produced via a nitromethane elimination from the Michael addition of the butylamine to 
nitroalkene 2 (Figure S2).15,16 In these Cu-catalyzed reactions, the relative yields of pyrrole 3 and 
by-products (1a and 2a) were determined by the 1H NMR spectrum after filtration of the crude 
mixture on a short pad of silica in order to remove the catalyst (Figure S3). Only Cu(OAc)2, CuI 
and [Cu(CH3CN)4]BF4 promote the formation of 3 in moderate yields 49%, 59% and 55%, 
respectively (Table 1, entries 2, 9 and 10); however, 20 mol% loading is required. Other Lewis 
acids, such as Sm(iOPr)3, AuCl3, AgNO3, Zn(ClO4)2 and Zn(NO3)2 showed poor catalytic 
performance under the present conditions (Table S2). Also, the reaction of 1, butyl amine and 2 in 
the presence of molten ammonium salt did not yield the corresponding pyrrole 3.13c The use of 
Cu-1 - Cu-4, in only 1 mol% loadings, give 3 in significantly increased yields (Table 1, entries 13 
– 16) when compared to metal salts (Table 1, entries 1 – 10). Cu-4 showcases superior behavior, 
with 89% yield (Table 1, entry 16). The use of 20 mol% of Cu(OTf)2 and 20 mol% ligand L yields 
3 in 45% yield (Table 1, entry 12), slightly higher when compared with Cu(OTf)2 (38% yield, 
Table 1, entry 4). In the later two cases, a significant amount of the two by-products 1a and 2a was 
identified by the crude 1H NMR after filtration over a small pad of silica. In addition, control 
experiments in which 20 mol% of Cu-4 and 1 mol% of CuI were performed. In the first case, the 
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corresponding pyrrole 3 was formed in a faster manner (ca. 20min) with 80% relative yield, 
although a significant amount (13%) of unidentified products was observed by 1H NMR of the 
crude reaction mixture (Table 1, entry 17). In contrary, in the latter case, 3 was formed in only 
31%, accompanying with 26% and 13% relative yields of the by-products 1a and 2a, respectively 
(result not shown). These results support the efficiency of the Cu-4 as catalyst with one order of 
magnitude less loading compared to the corresponding salt (1 mol%), as well as highlights the 
need of a well-defined and characterized catalyst for this process. Notably, in the absence of 
catalyst, 3 is formed in only 25% yield along with significant amounts of the by-products 1a and 
2a (Table 1, entry 11). Further, the use of aniline and 4-methoxyaniline result in a mixture of 
unidentified products; whereas no reaction was observed in the presence of benzaldehyde or p-
tolualdehyde (Figures S4 and S5). 
 






Relative yields (%)c 
   3 1a 2a 
1 Cu(NO3)2 3H2O 78 19 16 9 
2 Cu(OAc)2 H2O 100 49 18 11 
3 Cu(ClO4)2 6H2O 80 20 15 8 
4 Cu(OTf)2 100 38 23 12 
5 Cu(BF4)2 100 21 29 8 
6 CuSO4 5H2O 77 34 10 5 
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7 CuBr2 65 32 6 4 
8 CuBr 71 38 12 4 
9 CuI 100 59 17 12 
10 [Cu(CH3CN)4]BF4 100 55 14 9 
11d — 100 25 30 12 
12e Cu(OTf)2 + L 100 45 20 9 
13 Cu-1 100 76 12 4 
14 Cu-2 85 50 15 4 
15 Cu-3 100 70 14 6 
16 Cu-4 100 89 4 2 
17f Cu-4 100 80 5 2 
aConditions: 1 (0.2 mmol), BuNH2 (0.2 mmol), 2 (0.2 mmol), MeOH (1 
mL), at refluxfor 1h. The Cu salts were used in 20% mol, however Cu-1 – 
Cu-4 were used in 1mol%, based on 2 amount. bBased on the consumption 
of 2 determined from the crude 1H NMR mixture of the reaction. cRelative 
yields determined by 1H NMR of the crude mixture. In the case of Cu-salts 
catalyzed reactions, significant amounts of unidentified products were 
observed by 1H NMR (see also Figure S3). dA significant amount of the 
corresponding imine 2b formed from the reaction between 1 and BuNH2 
remain intact and observed by 1H NMR spectrum of the crude mixture. e20 
mol% ligand L (benzotriazole) was added into the reaction mixture. fThe 
Cu-4 was used in 20% mol and significant amount of unidentified products 
(13%) was observed by 1H NMR within 20 min (not shown). 
 
Herein the formation of 3 proceeds via a 1,2-phenyl migration,17 a process that is not previously 
observed;12,13 thus the scope and limitations of this reaction were explored with respect to the 
aldehyde moiety. Ιn this context, 2-phenyl propionaldehyde (1) was initially used with a variety of 
amines (alkyl or benzyl) and nitroalkenes (aryl or alkyl) and the results are shown in Figure 1. 
Interestingly, the corresponding 1,2,3,4-tetrasubstituted pyrroles (3 - 15) were isolated in high 
yields. The pyrroles were characterized by HRMS and NMR spectroscopy, although their 
structures were determined by 1D NOE-NMR experiments, indicating that the phenyl group is 
located at the C-2 position of the pyrrole ring. The pyrrole derivatives 6 and 7 were characterized 
by single X-ray diffraction (Figures S6 and S7). It is worth noting that the use of aliphatic 
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nitroalkenes (isopropyl and cyclohexyl derivatives) leads to the corresponding pyrroles 14 and 15 
in good isolated yields, 78% and 83% respectively (Figure 1), results that support the general 
applicability of the present methodology. 
 
Figure 1. Cu-Catalyzed Synthesis of 1,2,3,4-Tetrasubstituted Pyrroles from 2-Phenyl 




To expand the scope of this methodology, α-alkyl substituted aliphatic aldehydes, such as 2-
methyl butyraldehyde (R1 = Et) and 2-methyl propionaldehyde (R1 = Me), were employed with a 
variety of amines and nitroalkenes. As shown in Figure 2, the corresponding pyrroles (16 - 27) 
were formed as major products in good to high isolated yields (75% - 90%), regardless of the 
nature of amine and nitroalkene. The values in parentheses show the isolated yields of the 
corresponding pyrroles, as well as the appropriate time for reaction completion based on TLC 
analysis. In all cases, an analogous 1,2-methyl and 1,2-ethyl migration was observed to further 
support the potential of this protocol for the selective synthesis of polysubstituted pyrroles. 
Figure 2. Cu-Catalyzed Synthesis of Various 1,2,3,4-Tetrasubstituted Pyrroles from α-
Methyl Substituted Aliphatic Aldehydes, Amines and Nitroalkenes 
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It is interesting that under the present methodology even the use of β-methyl substituted 
nitrostyrenes, such as (E)-(2-nitroprop-1-en-1-yl)benzene and (E)-1-methyl-4-(2-nitroprop-1-en-
1-yl)benzene, yields the corresponding pentasubstituted pyrroles (28 - 32) in high isolated yields 
in the range of 80% - 87% (Figure 3). On the contrary, α-methyl substituted nitrostyrene, (1-
nitroprop-1-en-2-yl)benzene, degrades to the by-product acetophenone 1a, as shown in Figure S8. 
Figure 3. Cu-Catalyzed Synthesis of Pentasubstituted Pyrroles Starting with β-Methyl 
Substituted Nitrostyrenes 
 
The general applicability of the present Cu-catalytic system (Cu-4) was verified by 
performing reaction between non α-alkyl substituted aldehydes, such as 3-methylbutanal (R3 = i-
Pr), pentanal (R3 = Pr), 3-phenyl propionaldehyde (R3 = PhCH2) or phenylacetaldehyde (R
3 = Ph), 
with BuNH2 or benzyl amine and a series of β-nitrostyrenes. As shown in Figure 4, in all cases the 
corresponding 1,3,4-trisubstituted pyrroles 33 - 41 were formed in good to high isolated yield 67% 
– 90%. Based on these promising results, the Cu-4 catalyst was further used for possible larger-
scale production of pyrrole. Thus, a reaction with 3 mmol of nitrostyrene 2, 3 mmol of aldehyde 
1, 3 mmol of BuNH2 and Cu-4 (0.3 mol %) in 10 mL MeOH, was performed. After reaction 
completion (~3 h based on TLC analysis), the corresponding pyrrole 3 was isolated in 71% yield. 
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This result corresponds to a high turnover number (TON) of 237 as measured from the ratio of 
product 3 (mmol) / Cu-4 (mmol), and turnover frequency (TOF) value of 79 h-1. 
Figure 4. Synthesis of 1,3,4-Trisubstituted Pyrroles under Cu-Catalyzed Conditions 
 
Regarding the reaction mechanism, we observed the following: 
a) The reaction, under N2 saturated solution, proceeds with similar conversion and relative 
product yield of 3 (87%). However, under O2 saturated solution, a significant decrease in the yield 
of the pyrrole 3 (35%) and increase in the yield of the corresponding degradation product 
acetophenone 1a, in ca. 30% relative yield, were observed (Table S1, entries 2 and 3). Also, the 
use of 50 mol% of TEMPO decreases the reaction conversion to 90% and the relative yield of 3 to 
37% (Table S1, entry 4). These results support the predominance of a radical pathway, although a 
plausible Lewis acid mediated reaction pathway cannot be excluded (Scheme 3).18 
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b) The use of 3-propiophenone (1’) in place of 2-phenyl propionaldehyde 1, did not yield the 
expected pyrrole 3 (Scheme 2). In addition, the use of 3-pentanone, propiophenone or 
acetophenone, in place of 1, did not promote the transformation (Scheme 2). These observations 
may exclude the use of ketones as starting carbonyl compounds and support the necessity of α-
substituted aldehydes towards the convenient synthesis of polysubstituted pyrroles. Probably, a 
transient slowly formation of the corresponding enamine can be an explanation of the observed 
incompatibility of using ketones as starting materials.  
c) The use of other conjugated compounds, such as trans-methyl cinnamate, in place of β-
nitrostyrene 2, showed no reactivity under the present conditions (Scheme 2). However, the use of 
methyl propiolate or dimethyl acetylene dicarboxylate (DMAD),19 instead of β-nitrostyrene 2, 
yield a mixture of unidentified products (Scheme 2). These results indicate the necessity of the 
conjugated nitroalkenes for the pyrrole synthesis. 
d) The in-situ mixture of equivalent amounts of ligand L (20% mol) and Cu(OTf)2 (20% mol) 
in the given reaction slightly increases the relative yield of pyrrole 3 to 45% (from 38% in absence 
of L), whereas the formation of other by-products is observed. In addition, This result indicates 
that the use of the well-characterized catalyst, i.e. Cu-4 in such low loading 1%, in which the Cu 
center has a pre-determined octahedral (N4O2) geometry, provides, in high yields, the catalytically 
active specie (we envisage this to be the CuIIL(TfO)2, see text below and Figure S9 and precludes 
the, in-situ, formation of other non-catalytically active CuxLy species (not shown).  
e) Finally, the nature of the protic solvent has a significant role to the reaction process. MeOH 
promotes the catalytic reaction in a faster and selective manner when compared to EtOH or tBuOH 
(Table S1). Interestingly, a significant increase of pyrrole 3 relative yield (51%) was observed 
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when the reaction was carried out in CF3CH2OH as solvent, compared to EtOH, in which a 22% 
of 3 was measured. These results support the reaction promotion by the alcoholic media, as well 
as dependence on the pyrrole 3 relative yield and the different pKa values of the alcoholic solvents 
was observed.20 In addition, experiment in CF3CH2OH and in the absence of catalyst (Cu-4) gave 
a lower relative yield of 3 (35%) with significant amounts of the by-products 1a (21%) and 2a 
(14%) and the remain imine 2b (25%) (Table S1). This result confirms the catalytic enhancement 
of the present synthetic methodology. However, the use of CF3CH2OH as solvent is not 
recommended for environmental and costing reasons.  
Scheme 2. Substrate Evaluation for the Cu(II)-Catalyzed Synthesis of Pyrroles 
 
Regarding the active catalytic species, taking into account: i) the ESI-MS spectra of Cu-4 (see 
Figure S10 for its structure) in methanolic solution shows the presence of various speciation, ii) 
the partial dissociation of the ligand (L) from the coordination sphere of the Cu center; observed 
in the crude 1H-NMR spectra when higher loadings of Cu-4 were involved, iii) the crystallographic 
characterization of the “de-activated” catalyst, formulated as Cu(I)LCl2 in previous studies,11a iv) 
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the significant decrease in the yield of the pyrrole formation (Table 1 entry 13) when Cu-3 is used 
in which the coordination geometry of the Cu(II) center and the anion are different when compared 
with Cu-4, v) the reversible Cu(II)L2(OTf)2↔ Cu(I)L2(OTf) behavior as observed in cyclic 
voltammetry studies,11b and vi) other reports in which organic transformations are promoted from 
the suggested tetrasubstituted CuN2X2 species,
21 we envisage that [Cu(II)L(TfO)2] (Figure S9) 
might be the catalytically active specie.11,22 Efforts to isolate as well crystallographically and 
spectroscopically characterize other derivatives of the catalyst Cu-4 are in progress. 
Based on these observations, we propose that the first step involves the formation of the imine 
from the aldehyde and amine. Then, the imine probably tautomerizes to the corresponding 
enamine, which in turn reacts with the active species of the catalyst (Scheme 3). Ligand exchange 
with enamine yields the amino–Cu(II) intermediate A, which is in equilibrium with the nitrogen 
radical B and the Cu(I) complex C.21,23 In the presence of the β-nitrostyrene (excellent radical 
acceptor), the nitrogen radical B couples with the double bond, generating the intermediate D, 
which in turn is transformed into the desired cyclo-intermediate E through a proton 
elimination/1,2-phenyl migration cyclization process. The reactions under the O2 saturated 
solution and in the presence of TEMPO probably prevent the formation of this radical intermediate 
leading to the degradation product acetophenone 1a in significant amount, as described above. 
Finally, after the HNO and H2O elimination and the Cu-catalyst regeneration, intermediate E 
converts to the desired pyrrole (Scheme 3). A similar N-radical intermediate mechanism was 
proposed in the Cu(II) promoted coupling reactions between vinyl arenes and anilines, as well as 
intramolecular alkene oxidative amination for the synthesis of indoles.23 Further mechanistic 
studies to support the present proposed catalytic mechanism are in progress using different mono 
nuclear Cu(II) and Cu(I) complexes as well as deuterium labeled organic starting materials. 
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Scheme 3. Proposed Mechanism for the Cu(II)-Catalyzed Reaction of α-Methyl Substituted 




In conclusion, the one-pot Copper(II) catalyzed regioselective protocol of polysubstituted 
pyrroles from commercial available β-nitroalkenes, α-alkyl substituted aldehydes and amines is 
been presented. The reaction proceeds under mild catalytic conditions with low catalyst loading 
(0.3 - 1mol %), a broad scope, very good functional-group tolerance and can be easily scaled up. 
The access to a wide range of tri-, tetra- or pentasubstituted pyrroles, via an overwhelming 1,2-
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phenyl/alkyl migration, dependent on the aldehyde moiety, represents, the exceptional prospect of 
this synthetic protocol and to the best of our knowledge this opportunity was not feasible before. 
The use of ketones, in place of α-alkyl substituted aldehydes, does not promote the transformation 
showcasing the necessity of the use of α-substituted aldehydes in the present catalytic conditions. 
From the mechanistic point of view, a possible radical pathway is proposed including the formation 




General: Chemicals (reagent grade) were purchased from Sigma-Aldrich, Acros Organics, and 
Alfa Aesar. Materials and solvents were used with no further purification. Safety note: perchlorate 
salts are potentially explosive; such compounds should be used in small quantities and handled 
with caution and utmost care at all times.  
Preparation of catalysts: Ligand L and compounds Cu-1 – Cu-4 were synthesized according 
to the reported procedure.11 
Catalytic procedure for the synthesis of pyrroles: To a sealed tube containing equimolar 
amounts of the aldehyde (0.2 mmol) and the tube containing equimolar amounts of the aldehyde 
(0.2 mmol) and the amine (0.2 mmol) in methanol (1 mL), 0.2 mmol of the nitroalkene and 1 mol% 
of the catalyst were added and the mixture was stirred at reflux for the appropriate time. After 
reaction completion (monitored by TLC), the slurry was filtered through a short pad of Celite and 
silica gel to withhold the catalyst using MeOH (~5 mL) as an eluent. The solvent was then 
evaporated under vacuum and the residue was separated by column chromatography using silica 
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gel and the mixture solvent hexane/EtOAc = from 50/1 to 20/1 as eluent, to give the corresponding 
pyrrole in pure form. It is worth noting that, electron rich polysubstituted pyrroles are unstable 
molecules during the chromatographic purification procedure. For this reason, neutralized silica 
(with the addition of a few drops of triethylamine in the eluent solvent mixture) was used for the 
column chromatography, as well as pretreated CDCl3 with K2CO3 was used for accomplished the 
NMR spectra. Product analysis was conducted by 1H NMR and 13C NMR spectroscopy (Agilent 
AM 500). Mass spectra were determined on an electrospray ionization mass spectrometry (ESI-
MS), by using a ThermoFisher Scientific (Bremen, Germany) model LTQ Orbitrap Discovery MS, 
at a flow rate of 10 μL/min using syringe pump. The infusion experiments were run using a 
standard ESI source operating in a positive ionization mode. Source operating conditions were a 
3.7 kV spray voltage and a 300 oC heated capillary temperature. LCMS-2010 EV Instrument 
(Shimadzu) under Electrospray Ionization (ESI) conditions and on a MS EV AutospecFissins 
instrument (EI at 70eV) were also used for the mass determination. 
Synthesis of aromatic β-nitrostyrenes: Aromatic β-nitrostyrenes were synthesized according 
to the literature procedure.24 To a solution of ammonium acetate (12.5 mmol) in acetic acid (10 
mL), p-substituted benzaldehyde (5 mmol) and nitromethane (15.5 mmol) were added in one 
portion. The mixture was heated at reflux for 4 hours. The reaction mixture was cooled at room 
temperature and then poured into ice-water to precipitate the corresponding nitrostyrene. After 
extraction with organic solvent (EtOAc) the organic layer was evaporated under vacuum and the 
residue was purified by column chromatography using silica gel, to give final the corresponding 
products in 55-72% yields. 
Synthesis of (E)-1-methyl-4-(2-nitroprop-1-en-1-yl)benzene: (E)-1-methyl-4-(2-nitroprop-
1-en-1-yl)benzene was synthesized according to the literature procedure.24 To a solution of 
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ammonium acetate (12.5 mmol) in acetic acid (10 mL), p-tolualdehyde (5 mmol) and nitroethane 
(15.5 mmol) were added. The mixture was heated at reflux for 4 hours. The reaction mixture was 
cooled at room temperature and then poured into ice-water to form the solid mixture of product 
that was isolated by filtration through a short path of silica. The organic solvent was then 
evaporated under vacuum and the residue was separated by column chromatography using silica 
gel to give the corresponding product in 59% yield. 
Synthesis of (E)-(1-nitroprop-1-en-2-yl)benzene: (E)-(1-nitroprop-1-en-2-yl)benzene was 
synthesized according to the literature procedure.25 To a sealed tube charged with molecular sieves, 
DCE (5 mL), α-methyl styrene (2 mmol), silver nitrite (3 mmol) and TEMPO (1 mmol) were added 
in one portion. The mixture was heated at 70 °C for 12 hours. The reaction mixture was cooled at 
room temperature and filtered through a short pad of Celite with ethyl acetate as eluent. The 
organic solvent was then evaporated under vacuum and the residue was separated by column 
chromatography using silica gel to give the corresponding product in 80% yield. 
Synthesis of aliphatic nitroalkenes: Aliphatic nitroalkenes were synthesized according to the 
literature procedure.26 Το a solution of aliphatic aldehyde (5 mmol) and nitromethane (5 mmol) in 
methanol (4 mL), a solution of sodium hydroxide (6 mmol) in ice-water (2 mL) was added 
dropwise at 0 °C. External 2 mL of methanol were added into the above reaction mixture and 
stirred at 0 °C for 1 hour. Then water was added and the mixture was acidified with concentrated 
hydrochloric acid. The aqueous mixture was extracted with DCM (10 mL x3) and the combined 
organic layers were dried over sodium sulfate. The organic solvent was then evaporated under 
vacuum and the residue was separated by column chromatography using silica gel to give the 
corresponding products in pure form in 35-65% yields. 
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1-butyl-3-methyl-2-phenyl-4-(p-tolyl)-1H-pyrrole (3): colorless oil (54 mg, 89% yield). 1H 
NMR (500 MHz, CDCl3): 7.46 – 7.43 (m, 2H), 7.40 – 7.35 (m, 5H), 7.20 (d, J = 8.0 Hz, 2H), 6.83 
(s, 1H), 3.81 (t, J = 7.4 Hz, 2H), 2.38 (s, 3H), 2.13 (s, 3H), 1.63 – 1.57 (m, 2H), 1.25 – 1.18 (m, 
2H), 0.82 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 134.7, 133.7, 132.9, 131.9, 130.6, 
129.0, 128.2, 127.6, 127.0, 123.9, 118.4, 114.4, 46.9, 33.5, 21.1, 19.8, 13.6, 11.3. HRMS 
(ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C22H26N 304.2060; found 304.2047. 
1-butyl-3-methyl-2,4-diphenyl-1H-pyrrole (4): colorless oil (51 mg, 88% yield). 1H NMR (500 
MHz, CDCl3): 7.49 (d, J = 7.3 Hz, 2H), 7.46 – 7.43 (m, 2H), 7.39 – 7.35 (m, 5H), 7.22 (t, J = 7.3 
Hz, 1H), 6.86 (s, 1H), 3.82 (t, J = 7.4 Hz, 2H), 2.14 (s, 3H), 1.63 – 1.57 (m, 2H), 1.26 – 1.18 (m, 
2H), 0.82 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 136.7, 132.9, 132.1, 130.6, 128.3, 
128.2, 127.7, 127.1, 125.2, 124.0, 118.6, 114.4, 46.9, 33.5, 19.8, 13.6, 11.3. HRMS (ESI/LTQ 
Orbitrap) m/z: [M + H]+ calcd for C21H24N 290.1903; found 290.1891. 
1-butyl-4-(4-chlorophenyl)-3-methyl-2-phenyl-1H-pyrrole (5): colorless oil (58 mg, 90% 
yield). 1H NMR (500 MHz, CDCl3): 7.46 – 7.32 (m, 9H), 6.83 (s, 1H), 3.80 (t, J = 7.3 Hz, 2H), 
2.10 (s, 3H), 1.61 – 1.57 (m, 2H), 1.24 – 1.17 (m, 2H), 0.81 (t, J = 7.3 Hz, 3H). 13C NMR (125 
MHz, CDCl3): 135.2, 132.7, 132.3, 130.9, 130.6, 128.8, 128.4, 128.3, 127.2, 122.9, 118.6, 114.3, 
46.9, 33.5, 19.8, 13.6, 11.3. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C21H23ClN 
324.1514/326.1484; found 324.1509/326.1482. 
1-benzyl-3-methyl-2-phenyl-4-(p-tolyl)-1H-pyrrole (6): white crystals (60 mg, 89% yield), mp. 
142-144. 1H NMR (500 MHz, CDCl3): 7.40 – 7.38 (m, 4H), 7.34 – 7.22 (m, 6H), 7.19 (d, J = 7.9 
Hz, 2H), 7.03 (d, J = 7.0 Hz, 2H), 6.82 (s, 1H), 5.02 (s, 2H), 2.38 (s, 3H), 2.18 (s, 3H). 13C NMR 
(125 MHz, CDCl3): 138.6, 134.9, 133.5, 132.6, 132.5, 130.7, 129.0, 128.5, 128.2, 127.6, 127.23, 
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127.16, 126.8, 124.7, 119.2, 114.8, 50.8, 21.1, 11.4. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ 
calcd for C25H24N 338.1903; found 338.1889. 
1-benzyl-4-(4-bromophenyl)-3-methyl-2-phenyl-1H-pyrrole (7): white crystals (70 mg, 87% 
yield). 1H NMR (500 MHz, CDCl3): 7.47 (d, J = 8.5 Hz, 2H), 7.38 (d, J = 7.5 Hz, 2H), 7.36 – 7.32 
(m, 3H), 7.30 – 7.26 (m, 5H), 7.01 (d, J = 7.5 Hz, 2H), 6.82 (s, 1H), 5.00 (s, 2H), 2.14 (s, 3H). 13C 
NMR (125 MHz, CDCl3): 138.5, 135.5, 132.9, 132.4, 131.4, 130.7, 129.3, 128.6, 128.4, 127.5, 
127.4, 126.9, 123.7, 119.3, 119.2, 110.1, 50.9, 11.4. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ 
calcd for C24H21BrN 402.0857/404.0837; found 401.0841/403.0823. 
1-isopropyl-3-methyl-2,4-diphenyl-1H-pyrrole (8): colorless oil (48 mg, 87% yield). 1H NMR 
(500 MHz, CDCl3): 7.51 (d, J = 7.5 Hz, 2H), 7.46 (t, J = 7.5 Hz, 2H), 7.40 – 7.35 (m, 5H), 7.22 (t, 
J = 7.3 Hz, 1H), 6.95 (s, 1H), 4.30 (sept, J = 6.7 Hz, 1H), 2.13 (s, 3H), 1.38 (d, J = 6.7 Hz, 6H). 
13C NMR (125 MHz, CDCl3): 136.8, 133.0, 131.8, 130.8, 128.3 (2C), 127.6, 127.1, 125.2, 124.4, 
114.2, 114.0, 47.3, 24.0, 11.2. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C20H22N 
276.1747; found 276.1736. 
3-methyl-2-phenyl-4-(p-tolyl)-1-(4,4,4-trifluorobutyl)-1H-pyrrole (9): colorless oil (32 mg, 
89% yield). 1H NMR (500 MHz, CDCl3): 7.47 (t, J = 7.6 Hz, 2H), 7.42 -7.37 (m, 3H), 7.37 -7.34 
(m, 2H), 7.22 (d, J = 8.1 Hz, 2H), 6.81 (s, 1H), 3.93 (t, J = 7.0 Hz, 2H), 2.40 (s, 3H), 2.14 (s, 3H), 
1.96-1.85 (m, 2H), 1.86-1.78 (m, 2H). 13C NMR (125 MHz, CDCl3): 135.1, 133.5, 132.0, 130.6, 
129.4, 129.1, 128.7 (q, J = 288.2 Hz), 128.5, 128.2, 127.7, 127.4, 118.4, 115.4, 45.9, 30.9 (q, J = 
29.3 Hz), 23.8 (q, J = 3.0 Hz), 21.1, 11.3. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for 
C22H23F3N 358.1742; found 358.1728. 
1-cyclopentyl-3-methyl-2-phenyl-4-(p-tolyl)-1H-pyrrole (10): colorless oil (53 mg, 84% yield). 
1H NMR (500 MHz, CDCl3): 7.46 (t, J = 7.6 Hz, 2H), 7.40 – 7.35 (m, 5H), 7.20 (d, J = 7.8 Hz, 
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2H), 6.91 (s, 1H), 4.40 (p, J = 7.6 Hz, 1H), 2.38 (s, 3H), 2.12 (s, 3H), 2.06 – 2.02 (m, 2H), 1.87 – 
1.84 (m, 4H), 1.59 (brs, 2H). 13C NMR (125 MHz, CDCl3): 134.7, 133.8, 133.2, 132.4, 130.8, 
129.0, 128.2, 127.6, 127.1, 124.4, 114.5, 114.0, 57.2, 34.3, 24.4, 21.1, 11.2. HRMS (ESI/LTQ 
Orbitrap) m/z: [M + H]+ calcd for C23H26N 316.2060; found 316.2045. 
3-methyl-2-phenyl-1-propyl-4-(p-tolyl)-1H-pyrrole (11): colorless oil (26 mg, 89% yield). 1H 
NMR (500 MHz, CDCl3): 7.46 (t, J = 7.6 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 7.40-7.35 (m, 3H), 
7.22 (d, J = 8.0 Hz, 2H), 6.85 (s, 1H), 3.79 (t, J = 7.4 Hz, 2H), 2.40 (s, 3H), 2.16 (s, 3H), 1.69-1.61 
(m, 2H), 0.83 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 134.7, 133.1, 132.0, 130.7, 129.3, 
129.0, 128.2, 127.7, 127.0, 124.0, 118.5, 114.5, 48.9, 24.6, 21.1, 11.3, 11.2. HRMS (ESI/LTQ 
Orbitrap) m/z: [M + H]+ calcd for C21H24N 290.1864; found 290.1856. 
4-(4-fluorophenyl)-3-methyl-2-phenyl-1-propyl-1H-pyrrole (12): colorless oil (25 mg, 86% 
yield). 1H NMR (500 MHz, CDCl3): 7.48-7.41 (m, 4H), 7.36-7.32 (m, 3H), 7.06 (t, J = 8.7 Hz, 
2H), 6.81 (s, 1H), 3.77 (t, J = 7.5 Hz, 2H), 2.10 (s, 3H), 1.68-1.60 (m, 2H), 0.81 (t, J = 7.5 Hz, 
3H). 13C NMR (125 MHz, CDCl3): 161.2 (d, J = 243.2 Hz), 133.0, 132.8 (d,J = 3.2 Hz), 130.7, 
129.1 (d, J = 7.7 Hz), 128.3, 127.2, 123.2, 118.5, 115.1 (d, J = 21.0 Hz), 115.0, 114.4, 110.0, 48.9, 
24.7, 11.2 (2). HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C20H21FN: 294.1613; found 
293.1608. 
4-(4-methoxyphenyl)-3-methyl-2-phenyl-1-propyl-1H-pyrrole (13): colorless oil (24 mg, 79% 
yield). 1H NMR (500 MHz, CDCl3): 7.43 (t, J = 7.1 Hz, 2H), 7.40 (d, J = 8.5 Hz, 2H), 7.36-7.32 
(m, 3H), 6.93 (d, J = 8.5 Hz, 2H), 6.79 (s, 1H), 3.84 (s, 3H), 3.77 (t, J = 7.0 Hz, 2H), 2.11 (s, 3H), 
1.68-1.59 (m, 2H), 0.81 (t, J = 7.0 Hz, 3H). 13C NMR (125 MHz, CDCl3): 161.5, 133.2, 130.7, 
129.4, 129.1, 128.9, 128.3, 128.2, 127.1, 118.2, 113.9, 110.1, 55.3, 48.9, 24.7, 11.3 (2). HRMS 
(ESI/LTQ Orbitrap) m/z: [M + Η]+ calcd for C21H24NO 306.2850; found 305.2843. 
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1-butyl-4-isopropyl-3-methyl-2-phenyl-1H-pyrrole (14): colorless oil (40 mg, 78% yield). 1H 
NMR (500 MHz, CDCl3): 7.40 (t, J = 7.4 Hz, 2H), 7.32 – 7.29 (m, 3H), 6.48 (s, 1H), 3.73 (t, J = 
7.4 Hz, 2H), 2.86 (sept, J = 6.8 Hz, 1H), 1.99 (s, 3H), 1.60 – 1.54 (m, 2H), 1.24 (d, J = 6.8 Hz, 
6H), 1.22 – 1.16 (m, 2H), 0.81 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 133.2, 130.8, 
130.5, 129.6, 128.1, 126.6, 115.7, 114.5, 46.7, 33.6, 25.4, 23.6, 19.9, 13.7, 10.0. HRMS (ESI/LTQ 
Orbitrap) m/z: [M + H]+ calcd for C18H26N 256.1823; found 256.1810. 
1-butyl-4-cyclohexyl-3-methyl-2-phenyl-1H-pyrrole (15): colorless oil (49 mg, 83% yield). 1H 
NMR (500 MHz, CDCl3): 7.41 (t, J = 7.5 Hz, 2H), 7.31 – 7.30 (m, 3H), 6.46 (s, 1H), 3.74 (t, J = 
7.4 Hz, 2H), 2.48 – 2.44 (m, 1H), 2.02 (s, 2H), 1.99 (s, 3H), 1.82 (d, J = 12.6 Hz, 2H), 1.75 (d, J 
= 12.6 Hz, 1H), 1.60 – 1.54 (m, 2H), 1.45 – 1.25 (m, 5H), 1.24 – 1.16 (m, 2H), 0.82 (t, J = 7.4 Hz, 
3H).13C NMR (125 MHz, CDCl3): 133.3, 130.6, 130.5, 128.9, 128.0, 126.6, 116.0, 114.5, 46.7, 
35.6, 34.3, 33.6, 27.1, 26.5, 19.9, 13.7, 10.0. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for 
C21H30N 296.2373; found 296.2359. 
1-butyl-2-ethyl-3-methyl-4-(p-tolyl)-1H-pyrrole (16): colorless oil (45 mg, 88% yield). 1H 
NMR (500 MHz, CDCl3): 7.31 (d, J = 8.0 Hz, 2H), 7.16 (d, J = 8.0 Hz, 2H), 6.63 (s, 1H), 3.80 (t, 
J = 7.5 Hz, 2H), 2.61 (q, J = 7.5 Hz, 2H), 2.36 (s, 3H), 2.15 (s, 3H), 1.78 – 1.72 (m, 2H), 1.44 – 
1.36 (m, 2H), 1.16 (t, J = 7.5 Hz, 3H), 0.97 (t, J = 7.5 Hz, 3H). 13C NMR (125 MHz, CDCl3): 
134.6, 134.2, 131.7, 129.1, 127.8, 123.5, 116.7, 112.0, 46.5, 34.0, 21.2, 20.3, 17.7, 14.9, 14.0, 10.6. 
HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C18H26N 256.2060; found 256.2054. 
1-butyl-2-ethyl-3-methyl-4-phenyl-1H-pyrrole (17): colorless oil (41 mg, 86% yield). 1H NMR 
(500 MHz, CDCl3): 7.42 (d, J = 7.5 Hz, 2H), 7.34 (t, J = 7.5 Hz, 2H), 7.18 (t, J = 7.4 Hz, 1H), 6.66 
(s, 1H), 3.81 (t, J= 7.4 Hz, 2H), 2.61 (q, J = 7.5 Hz, 2H), 2.16 (s, 3H), 1.78 – 1.72 (m, 2H), 1.44 – 
1.36 (m, 2H), 1.17 (t, J = 7.5 Hz, 3H), 0.97 (t, J = 7.4 Hz, 3H).13C NMR (125 MHz, CDCl3): 137.0, 
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131.7, 128.2, 127.7, 125.0, 123.4, 116.8, 111.9, 46.3, 33.8, 20.2, 17.6, 14.8, 13.8, 10.5. HRMS 
(ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C17H24N 242.1903; found 242.1892. 
1-butyl-4-(4-chlorophenyl)-2-ethyl-3-methyl-1H-pyrrole (18): colorless oil (45 mg, 81% yield). 
1H NMR (500 MHz, CDCl3): 7.33 (d, J = 8.5 Hz, 2H), 7.29 (d, J = 8.5 Hz, 2H), 6.64 (s, 1H), 3.80 
(t, J = 7.5 Hz, 2H), 2.60 (q, J = 7.5 Hz, 2H), 2.13 (s, 3H), 1.77 – 1.71 (m, 2H), 1.43 – 1.35 (m, 
2H), 1.15 (t, J = 7.5 Hz, 3H), 0.96 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 135.5, 131.9, 
130.6, 128.7, 128.3, 122.3, 116.9, 111.8, 46.4, 33.8, 20.1, 17.5, 14.7, 13.8, 10.5. HRMS (ESI/LTQ 
Orbitrap) m/z: [M + H]+ calcd for C17H23ClN 276.1514/278.1484; found 276.1519/278.1495. 
4-(4-bromophenyl)-1-butyl-2-ethyl-3-methyl-1H-pyrrole (19): colorless oil (54 mg, 85% yield). 
1H NMR (500 MHz, CDCl3): 7.44 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H), 6.65 (s, 1H), 3.80 
(t, J = 7.5 Hz, 2H), 2.60 (q, J = 7.5 Hz, 2H), 2.13 (s, 3H), 1.77 – 1.71 (m, 2H), 1.43 – 1.35 (m, 
2H), 1.15 (t, J = 7.5 Hz, 3H), 0.97 (d, J = 7.5 Hz, 3H). 13C NMR (125 MHz, CDCl3): 135.9, 132.0, 
131.2, 129.1, 122.3, 118.7, 116.9, 111.8, 46.4, 33.8, 20.1, 17.5, 14.7, 13.8, 10.5. HRMS (ESI/LTQ 
Orbitrap) m/z: [M + H]+ calcd for C17H23BrN 320.1008/322.0988 found 320.1017/322.0995. 
1-benzyl-4-(4-chlorophenyl)-2-ethyl-3-methyl-1H-pyrrole (20): colorless oil (46 mg, 75% 
yield). 1H NMR (500 MHz, CDCl3): 7.37 – 7.27 (m, 7H), 7.08 (d, J = 7.5 Hz, 2H), 6.68 (s, 1H), 
5.06 (s, 2H), 2.55 (q, J = 7.5 Hz, 2H), 2.16 (s, 3H), 1.03 (t, J = 7.5 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): 138.4, 135.3, 132.4, 130.7, 128.8, 128.7, 128.3, 127.4, 126.5, 122.7, 117.9, 112.6, 50.4, 
17.6, 14.6, 10.5. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C20H21ClN 
310.1357/312.1328; found 310.1346/312.1307. 
1-butyl-2,3-dimethyl-4-(p-tolyl)-1H-pyrrole (21): colorless oil (39 mg, 81% yield). 1H NMR 
(500 MHz, CDCl3): 7.31 (d, J = 7.5 Hz, 2H), 7.17 (d, J = 7.5 Hz, 2H), 6.65 (s, 1H), 3.80 (t, J = 7.3 
Hz, 2H), 2.37 (s, 3H), 2.19 (s, 3H), 2.14 (s, 3H), 1.75 – 1.69 (m, 2H), 1.43 – 1.35 (m, 2H), 0.96 (t, 
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J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3): 134.5, 134.0, 128.9, 127.7, 125.4, 123.3, 116.8, 
112.5, 46.6, 33.5, 21.1, 20.0, 13.8, 10.6, 9.7. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for 
C17H24N 242.1903; found 242.1894. 
1-butyl-2,3-dimethyl-4-phenyl-1H-pyrrole (22): colorless oil (36 mg, 80% yield). 1H NMR (500 
MHz, CDCl3): 7.42 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.4 Hz, 2H), 7.20 (t, J = 7.4 Hz, 1H), 6.69 (s, 
1H), 3.81 (t, J = 7.4 Hz, 2H), 2.20 (s, 3H), 2.16 (s, 3H), 1.76 – 1.70 (m, 2H), 1.44 – 1.36 (m, 2H), 
0.97 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 137.0, 130.5, 128.2, 127.7, 125.0, 123.4, 
117.0, 112.5, 46.6, 33.4, 20.0, 13.8, 10.6, 9.7. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for 
C16H22N 228.1747; found 228.1738. 
1-butyl-4-(4-chlorophenyl)-2,3-dimethyl-1H-pyrrole (23): colorless oil (47 mg, 90% yield). 1H 
NMR (500 MHz, CDCl3): 7.33 (d, J = 8.6 Hz, 2H), 7.30 (d, J = 8.6 Hz, 2H), 6.66 (s, 1H), 3.80 (t, 
J = 7.4 Hz, 2H), 2.18 (s, 3H), 2.12 (s, 3H), 1.74 – 1.68 (m, 2H), 1.42 – 1.35 (m, 2H), 0.96 (t, J = 
7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 135.5, 130.7, 128.8, 128.3, 125.8, 122.2, 117.0, 112.4, 
46.7, 33.4, 20.0, 13.7, 10.6, 9.7. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C16H21ClN 
262.1357/264.1328; found 262.1352/264.1324. 
1-butyl-2,3-dimethyl-4-(naphthalen-1-yl)-1H-pyrrole (24): colorless oil (47 mg, 85% yield). 1H 
NMR (500 MHz, CDCl3): 8.03 (d, J = 8.2 Hz, 1H), 7.87 (d, J = 8.2 Hz, 1H), 7.78 (d, J = 8.2 Hz, 
1H), 7.49 – 7.39 (m, 4H), 6.65 (s, 1H), 3.87 (t, J = 7.4 Hz, 2H), 2.26 (s, 3H), 1.89 (s, 3H), 1.80 – 
1.74 (m, 2H), 1.46 – 1.39 (m, 2H), 0.99 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 135.0, 
133.8, 132.9, 128.0, 127.5, 127.1, 126.3, 125.4, 125.3 (2C), 124.6, 121.5, 118.5, 114.4, 46.6, 33.5, 
20.0, 13.8, 10.3, 9.9. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C20H24N 278.1903; 
found 278.1894. 
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1-benzyl-2,3-dimethyl-4-(p-tolyl)-1H-pyrrole (25): colorless oil (50 mg, 90% yield). 1H NMR 
(500 MHz, CDCl3): 7.34 – 7.31 (m, 4H), 7.27 – 7.25 (m, 1H), 7.17 (d, J = 7.9 Hz, 2H), 7.08 (d, J 
= 7.6 Hz, 2H), 6.71 (s, 1H), 5.03 (s, 2H), 2.36 (s, 3H), 2.15 (s, 3H), 2.10 (s, 3H). 13C NMR (125 
MHz, CDCl3): 138.3, 134.7, 133.9, 129.0, 128.7, 127.7, 127.3, 126.6, 125.9, 123.8, 117.7, 113.2, 
50.6, 21.1, 10.7, 9.8. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C20H22N 276.1747; 
found 276.1734. 
1-benzyl-2,3-dimethyl-4-phenyl-1H-pyrrole (26): colorless oil (44 mg, 85% yield). 1H NMR 
(500 MHz, CDCl3): 7.43 (d, J = 7.1 Hz, 2H), 7.36 – 7.31 (m, 4H), 7.27 – 7.25 (m, 1H), 7.20 (t, J 
= 7.3 Hz, 1H), 7.08 (d, J = 7.7 Hz, 2H), 6.74 (s, 1H), 5.04 (s, 2H), 2.16 (s, 3H), 2.11 (s, 3H). 13C 
NMR (125 MHz, CDCl3): 138.2, 136.8, 128.7, 128.2, 127.7, 127.3, 126.6, 126.1, 125.1, 123.9, 
117.9, 113.2, 50.6, 10.7, 9.8. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C19H20N 
262.1590; found 262.1581. 
1-benzyl-4-(4-chlorophenyl)-2,3-dimethyl-1H-pyrrole (27): colorless oil (49 mg, 83% yield). 
1H NMR (500 MHz, CDCl3): 7.36 – 7.27 (m, 7H), 7.07 (d, J = 7.5 Hz, 2H), 6.72 (s, 1H), 5.03 (s, 
2H), 2.14 (s, 3H), 2.11 (s, 3H). 13C NMR (125 MHz, CDCl3): 138.1, 135.3, 130.8, 128.8, 128.7, 
128.4, 127.4, 126.5, 126.4, 122.7, 117.9, 113.2, 50.7, 10.7, 9.8. HRMS (ESI/LTQ Orbitrap) m/z: 
[M + H]+ calcd for C19H19ClN 296.1201/298.1171; found 296.1189/298.1160. 
2,4-dimethyl-3,5-diphenyl-1-propyl-1H-pyrrole (28): colorless oil, (26 mg, 89% yield). 1H 
NMR (500 MHz, CDCl3): 7.48-7.35 (m, 10H), 3.78 (t, J = 7.5 Hz, 2H), 2.33 (s, 3H), 2.01 (s, 3H), 
1.64-1.55 (m, 2H), 0.80 (t, J = 7.5 Hz, 2H). 13C NMR (125 MHz, CDCl3): 137.0, 133.7, 130.8, 
130.2, 128.6, 128.4, 128.2, 127.9, 126.8, 125.3, 125.1, 114.5, 46.0, 24.5, 11.2, 11.0, 10.8. HRMS 
(ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C21H24N: 290.1858; found 289.1852. 
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1-butyl-2,4-dimethyl-5-phenyl-3-(p-tolyl)-1H-pyrrole (29): colorless oil (53 mg, 84% yield). 1H 
NMR (500 MHz, CDCl3): 7.44 (t, J = 7.6 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 7.34 (t, J = 7.8 Hz, 
1H), 7.27 – 7.25 (m, 2H), 7.22 (d, J = 7.8 Hz, 2H), 3.81 – 3.78 (m, 2H), 2.40 (s, 3H), 2.31 (s, 3H), 
1.99 (s, 3H), 1.58 – 1.52 (m, 2H), 1.23 – 1.16 (m, 2H), 0.81 (t, J = 7.4 Hz, 3H). 13C NMR (125 
MHz, CDCl3): 134.7, 133.8, 133.6, 130.7, 130.0, 129.9, 128.7, 128.1, 126.7, 125.0, 121.7, 114.4, 
44.1, 33.3, 21.2, 19.9, 13.6, 11.0, 10.8. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for 
C23H28N 318.2216; found 318.2200. 
1-butyl-2-ethyl-3,5-dimethyl-4-(p-tolyl)-1H-pyrrole (30): colorless oil (43 mg, 80% yield). 1H 
NMR (500 MHz, CDCl3):7.20 – 7.15 (m, 5H), 3.78 – 3.75 (m, 1H), 2.62 (q, J = 7.5 Hz, 2H), 2.38 
(s, 3H), 2.21 (s, 3H), 2.01 (s, 3H), 1.70 – 1.64 (m, 2H), 1.46 – 1.38 (m, 2H), 1.18 (t, J = 7.5 Hz, 
3H), 0.99 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, CDCl3): 134.4, 134.1, 130.0, 129.2, 128.6, 
122.8, 120.9, 111.6, 43.6, 33.9, 21.1, 20.3, 17.8, 15.2, 13.8, 10.7, 10.0. HRMS (ESI/LTQ Orbitrap) 
m/z: [M + H]+ calcd for C19H28N 270.2216; found 270.2209. 
2-ethyl-1-isopropyl-3,5-dimethyl-4-(p-tolyl)-1H-pyrrole (31): colorless oil (42 mg, 82% yield). 
1H NMR (500 MHz, CDCl3): 7.21-7.18 (m, 4H), 4.49 (sept, J = 7.1 Hz, 1H), 2.68 (q, J = 7.5 Hz, 
2H), 2.39 (s, 3H), 2.31 (s, 3H), 1.99 (s, 3H), 1.55 (d, J = 7.1 Hz, 6H), 1.18 (t, J = 7.5 Hz, 3H). 13C 
NMR (125 MHz, CDCl3): 134.4, 134.1, 130.3, 129.4, 128.5, 122.7, 122.1, 111.8, 46.9, 22.7, 21.1, 
18.4, 15.4, 12.5, 10.0. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C18H26N 256.2060; 
found 256.2046. 
1-cyclopentyl-2-ethyl-3,5-dimethyl-4-(p-tolyl)-1H-pyrrole (32): colorless oil (49 mg, 87% 
yield). 1H NMR (500 MHz, CDCl3): 7.22 – 7.17 (m, 4H), 4.61 (p, J = 9.3 Hz, 1H), 2.68 (q, J = 7.4 
Hz, 2H), 2.39 (s, 3H), 2.29 (s, 3H), 2.10 (br, 2H), 2.05 – 2.02 (m, 2H), 1.99 (s, 3H), 1.96 – 1.92 
(m, 2H), 1.73 – 1.71 (m, 2H), 1.19 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 134.5, 134.0, 
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130.2, 130.0, 128.6, 122.8, 122.3, 111.8, 56.3, 31.8, 25.1, 21.1, 18.4, 15.4, 12.5, 10.0. HRMS 
(ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C20H28N 282.2216; found 282.2206. 
1-butyl-3-isopropyl-4-(p-tolyl)-1H-pyrrole (33): colorless oil (44 mg, 86% yield).1H NMR (500 
MHz, CDCl3): 7.30 (d, J = 7.8 Hz, 2H), 7.16 (d, J = 7.8 Hz, 2H), 6.62 (s, 1H), 6.48 (s, 1H), 3.83 
(t, J = 7.4 Hz, 2H), 3.12 (sept, J = 6.8 Hz, 1H), 2.36 (s, 3H), 1.81 – 1.75 (m, 2H), 1.41 – 1.33 (m, 
2H), 1.17 (d, J = 6.8 Hz, 6H), 0.96 (t, J = 7.4 Hz, 3H).13C NMR (125 MHz, CDCl3): 134.7, 134.2, 
129.2, 128.9, 128.0, 123.2, 118.8, 116.8, 49.4, 33.5, 25.0, 24.4, 21.1, 20.1, 13.7. HRMS (ESI/LTQ 
Orbitrap) m/z: [M + H]+ calcd for C18H26N 256.2060, found 256.2055. 
1-butyl-3-isopropyl-4-phenyl-1H-pyrrole (34):12 colorless oil (42 mg, 87% yield). 1H NMR 
(500 MHz, CDCl3): 7.42 (d, J = 7.8 Hz, 2H), 7.35 (t, J = 7.8 Hz, 2H), 7.21 (t, J = 7.3 Hz, 1H), 6.66 
(d, J = 1.9 Hz, 1H), 6.50 (d, J = 1.9 Hz, 1H), 3.84 (t, J = 7.4 Hz, 2H), 3.15 (sept, J = 6.8Hz, 1H), 
1.82 – 1.76 (m, 2H), 1.41 – 1.34 (m, 2H), 1.18 (d, J = 6.8 Hz, 6H), 0.96 (t, J = 7.4 Hz, 3H).13C 
NMR (125 MHz, CDCl3): 137.2, 129.3, 128.2, 128.1, 125.2, 123.2, 118.9, 116.9, 49.4, 33.5, 25.0, 
24.4, 20.1, 13.7. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C17H24N 242.1903, found 
242.1895. 
1-butyl-3-isopropyl-4-(4-methoxyphenyl)-1H-pyrrole (35): colorless oil (36 mg, 67% yield). 1H 
NMR (500 MHz, CDCl3): 7.32 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.59 (d, J = 2.3 Hz, 
1H), 6.47 (d, J = 2.3 Hz, 1H), 3.84 – 3.81 (m, 5H), 3.08 (sept, J = 6.8Hz, 1H), 1.80 – 1.74 (m, 2H), 
1.40 – 1.33 (m, 2H), 1.16 (d, J = 6.8 Hz, 6H), 0.95 (t, J = 7.3 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): 157.6, 129.7, 129.20, 129.18, 122.9, 118.6, 116.7, 113.7, 55.2, 49.4, 33.5, 25.0, 24.3, 20.1, 
13.7. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C18H26NO 272.2009; found 272.2000. 
1-butyl-3-(4-chlorophenyl)-4-isopropyl-1H-pyrrole (36): colorless oil (50 mg, 90% yield). 1H 
NMR (500 MHz, CDCl3): 7.33 (d, J = 8.5 Hz, 2H), 7.29 (d, J = 8.5 Hz, 2H), 6.63 (d, J = 1.9 Hz, 
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1H), 6.48 (d, J = 1.9 Hz, 1H), 3.82 (t, J = 7.4 Hz, 2H), 3.08 (sept, J = 6.8Hz, 1H), 1.80 – 1.74 (m, 
2H), 1.40 – 1.32 (m, 2H), 1.16 (d, J = 6.8 Hz, 6H), 0.95 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): 135.7, 131.0, 129.2 (2C), 128.3, 122.0, 119.0, 117.2, 49.5, 33.5, 25.0, 24.3, 20.0, 13.7. 
HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C17H23ClN 276.1514/278.1484; found 
276.1515/278.1483. 
3-(4-bromophenyl)-1-butyl-4-isopropyl-1H-pyrrole (37): colorless oil (52 mg, 81% yield). 1H 
NMR (500 MHz, CDCl3): 7.45 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H), 6.64 (d, J = 2.0 Hz, 
1H), 6.49 (d, J = 2.0 Hz, 1H), 3.83 (t, J = 7.4 Hz, 2H), 3.08 (sept, J = 6.8Hz, 1H), 1.80 – 1.74 (m, 
2H), 1.40 – 1.33 (m, 2H), 1.16 (d, J = 6.8 Hz, 6H), 0.95 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): 136.1, 131.3, 129.6, 129.2 (2C), 122.0, 119.0, 117.2, 49.5, 33.4, 25.0, 24.3, 20.0, 13.7. 
HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C17H23BrN 320.1008/322.0988; found 
320.0997/322.0976. 
1-benzyl-3-isopropyl-4-(p-tolyl)-1H-pyrrole (38): colorless oil (44 mg, 76% yield). 1H NMR 
(500 MHz, CDCl3): 7.35 (t, J = 7.4 Hz, 2H), 7.32 – 7.29 (m, 3H), 7.19 (d, J = 7.4 Hz, 2H), 7.16 
(d, J = 7.7 Hz, 2H), 6.67 (d, J = 1.8 Hz, 1H), 6.54 (d, J = 1.8 Hz, 1H), 5.04 (s, 2H), 3.14 (sept, J = 
6.8 Hz, 1H), 2.37 (s, 3H), 1.18 (d, J = 6.8 Hz, 6H). 13C NMR (125 MHz, CDCl3): 138.1, 134.9, 
134.0, 130.0, 128.9, 128.7, 128.0, 127.6, 127.2, 123.8, 119.4, 117.5, 53.4, 25.0, 24.3, 21.1. HRMS 
(ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C21H24N 290.1903; found 290.1892. 
1-butyl-3-propyl-4-(p-tolyl)-1H-pyrrole (39): colorless oil (42 mg, 82% yield). 1H NMR (500 
MHz, CDCl3): 7.29 (d, J = 8.0 Hz, 2H), 7.15 (d, J = 8.0 Hz, 2H), 6.67 (d, J = 1.8 Hz, 1H), 6.47 (s, 
1H), 3.82 (t, J = 7.2 Hz, 2H), 2.58 – 2.55 (m, 2H), 2.35 (s, 3H), 1.79 – 1.73 (m, 2H), 1.61 – 1.53 
(m, 2H), 1.39 – 1.32 (m, 2H), 0.96 – 0.92 (m, 6H). 13C NMR (125 MHz, CDCl3): 134.6, 134.0, 
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128.9, 127.7, 123.6, 121.9, 118.9, 118.6, 49.3, 33.5, 28.3, 23.7, 21.1, 20.0, 14.3, 13.7. HRMS 
(ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C18H26N 256.2060; found 256.2050. 
3-benzyl-1-butyl-4-(p-tolyl)-1H-pyrrole (40): colorless oil (43 mg, 71% yield). 1H NMR (500 
MHz, CDCl3): 7.30 – 7.26 (m, 4H), 7.23 (d, J = 7.5 Hz, 2H), 7.18 (t, J = 7.2 Hz, 1H), 7.13 (d, J = 
7.8 Hz, 2H), 6.72 (s, 1H), 6.25 (s, 1H), 3.95 (s, 2H), 3.79 (t, J = 7.4 Hz, 2H), 2.34 (s, 3H), 1.77 – 
1.71 (m, 2H), 1.38 – 1.30 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz, CDCl3): 142.2, 
134.8, 133.5, 129.0, 128.8, 128.2, 127.7, 125.6, 123.9, 120.42, 120.39, 118.7, 49.4, 33.5, 32.3, 
21.1, 20.0, 13.7. HRMS (ESI/LTQ Orbitrap) m/z: [M + H]+ calcd for C22H26N 304.2060, found 
304.2043. 
1-butyl-3-phenyl-4-(p-tolyl)-1H-pyrrole (41): colorless oil (42 mg, 72% yield). 1H NMR (500 
MHz, CDCl3): 7.29 – 7.23 (m, 4H), 7.16 (d, J = 7.8 Hz, 3H), 7.06 (d, J = 7.8 Hz, 2H), 6.75 (s, 1H), 
6.74 (s, 1H), 3.90 (t, J = 7.3Hz, 2H), 2.33 (s, 3H), 1.85 – 1.80 (m, 2H), 1.45 – 1.37 (m, 2H), 0.97 
(t, J = 7.3Hz, 3H). 13C NMR (125 MHz, CDCl3): 136.1, 134.9, 133.0, 128.8, 128.3, 128.2, 128.1, 
125.3, 122.88, 122.85, 120.1, 120.0, 49.5, 33.4, 21.1, 20.0, 13.7. HRMS (ESI/LTQ Orbitrap) m/z: 
[M + H]+ calcd for C21H24N 290.1903; found 290.1889. 
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